{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:09:42Z","timestamp":1762099782095,"version":"build-2065373602"},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":228,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2001,5,6]]},"abstract":"<jats:p>Objective.\u2014To empirically test a clinical prediction rule for evaluating HIV\u2010infected patients complaining of headache and to identify those at low risk for intracranial mass lesion who do not need immediate computed tomography of the head.<\/jats:p>\n                  <jats:p>Design.\u2014Two retrospective clinical cohorts of HIV\u2010infected patients clinically evaluated for headache.<\/jats:p>\n                  <jats:p>Methods.\u2014To describe the headache clinical outcomes, medical records were abstracted from all HIV\u2010infected patients evaluated for headache with computed tomography of the head at two urban hospitals. Patients were categorized as low, intermediate, or high risk based on clinical criteria (focal neurological signs, altered mental status, history of seizure) and immune status (CD4 lymphocytes\u2264200\/\u03bcL). Records were abstracted from a second unselected cohort of HIV\u2010infected outpatients with headache who were all treated and followed in primary care (N=101).<\/jats:p>\n                  <jats:p>\n                    Results.\u2014Of 101 unselected HIV\u2010infected outpatients followed in primary care after headache, 1% (95% confidence interval [CI], 0% to 6%) had a treatable intracranial lesion. Of 364 HIV\u2010infected patients with headache sent for evaluation with computed tomography of the head, the rate of any abnormality was zero in the low\u2010risk group (95% CI, 0% to 10%; n\n                    <jats:bold>=<\/jats:bold>\n                    35); 9% in the intermediate\u2010risk group (95% CI, 2% to 16%; n\n                    <jats:bold>=<\/jats:bold>\n                    242); and 21% in the high\u2010risk group (95% CI, 12% to 29%; n\n                    <jats:bold>=<\/jats:bold>\n                    87).\n                  <\/jats:p>\n                  <jats:p>Conclusion.\u2014Most HIV\u2010infected patients with headache may be treated with analgesics and followed up clinically. Those without focal neurological signs, altered mental status, seizure, or decreased CD4 lymphocytes are unlikely to have intracranial mass lesions.<\/jats:p>","DOI":"10.1046\/j.1526-4610.2001.01081.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T18:17:38Z","timestamp":1047406658000},"page":"441-448","source":"Crossref","is-referenced-by-count":3,"title":["Evaluating HIV\u2010Infected Patients With Headache: Who Needs Computed Tomography?"],"prefix":"10.1111","volume":"41","author":[{"given":"Allen L.","family":"Gifford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick M.","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(91)90147-2"},{"volume-title":"Headache as the Reason for Office Visits. National Ambulatory Medical Care Survey, United States, 1977\u201078","year":"1981","author":"Cypress B","key":"e_1_2_7_3_2"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200007000-00007"},{"key":"e_1_2_7_5_2","first-page":"126","article-title":"Sensitivity, specificity, reliability, and clinical validity of provider\u2010reported symptoms: a comparison with self\u2010reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group.","volume":"21","author":"Justice AC","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-199005000-00001"},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1052-5149(25)00440-X","article-title":"Neuroimaging of AIDS. I. Central nervous system toxoplasmosis.","volume":"7","author":"Ramsey RG","year":"1997","journal-title":"Neuroimaging Clin N Am"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1052-5149(25)00448-4","article-title":"Primary central nervous system lymphoma in patients with AIDS.","volume":"7","author":"Ruiz A","year":"1997","journal-title":"Neuroimaging Clin N Am"},{"key":"e_1_2_7_9_2","doi-asserted-by":"crossref","unstructured":"Evaluation and management of intracranial mass lesions in AIDS .Report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology.1998;50:21\u201026.","DOI":"10.1212\/WNL.50.1.21"},{"volume-title":"Medical Management of HIV Infection","year":"1998","author":"Bartlett JG","key":"e_1_2_7_10_2"},{"volume-title":"Outpatient Management of HIV Infection","year":"1996","author":"Masci JR","key":"e_1_2_7_11_2"},{"volume-title":"AIDS Dx\/Rx","year":"1990","author":"Holmes KK","key":"e_1_2_7_12_2"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1992.00400240077013"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.7.1191"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-9-664"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370010081020"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198803313181301"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198509263131306"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.157.16.1825"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.269.5.622"},{"volume-title":"Geigy Scientific Tables. 8th rev and enl ed","year":"1981","author":"Lentner C","key":"e_1_2_7_21_2"},{"volume-title":"Statistical Methods for Rates and Proportions","year":"1981","author":"Fleiss JL","key":"e_1_2_7_22_2"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90045-D"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90046-E"},{"volume-title":"The Medical Management of AIDS","year":"1995","author":"Sande MA","key":"e_1_2_7_25_2"},{"volume-title":"Medical Decision Making","year":"1988","author":"Sox HC","key":"e_1_2_7_26_2"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-2-199907200-00002"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1526-4610.2001.01081.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-4610.2001.01081.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:03:30Z","timestamp":1762081410000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-4610.2001.01081.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,6]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5,6]]}},"alternative-id":["10.1046\/j.1526-4610.2001.01081.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-4610.2001.01081.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"type":"print","value":"0017-8748"},{"type":"electronic","value":"1526-4610"}],"subject":[],"published":{"date-parts":[[2001,5,6]]}}}